TAL
TEVA icon

TIG Advisors LLC’s Teva Pharmaceuticals TEVA Stock Holding History

TIG Advisors LLC’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-201,913
Closed -$11.9M – 60
2015
Q2 		$11.9M Buy
+201,913
New +$12.5M 0.57% 35

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

TIG Advisors LLC's TEVA Position: Q3 2015 in Review

TIG Advisors LLC sold out of Teva Pharmaceuticals (TEVA) in Q3 2015, closing a stake of 201,913 shares — an estimated $11.9M sold.

TIG Advisors LLC first reported a position in TEVA in Q2 2015 and held it in 1 quarter. The position peaked at $11.9M in Q2 2015. 823 funds tracked by Wall St. Rank hold TEVA as of Q3 2015.

  • TIG Advisors LLC reported no remaining Teva Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • TIG Advisors LLC sold 201,913 Teva Pharmaceuticals shares in Q3 2015, an estimated $11.9M.
  • TIG Advisors LLC first reported a position in Teva Pharmaceuticals in Q2 2015 and held it in 1 quarter.
  • TIG Advisors LLC's Teva Pharmaceuticals position peaked at $11.9M in Q2 2015.
  • 823 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2015.

Based on TIG Advisors LLC's 13F filing for Q3 2015, filed 16 Nov 2015.